This third of five exclusive episodes explores how clinicians can navigate newly approved MASH therapies -- resmetirom (Rezdiffra) and semaglutide (Wegovy) -- and how to tailor treatment choices based ...

The LDL-C reductions seen with enlicitide in both studies are in the same ballpark as those seen with injectable ...

Esperion faces pressure from emerging oral PCSK9i and CETP inhibitors, which offer superior LDL-c lowering. See why I rate ...

A statin isn’t the only answer anymore to lowering cholesterol. The lipid-reducing medicines, among the most widely prescribed drugs in the U.S., have been a mainstay of heart-disease prevention and ...

Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...

An oral agent is needed because some patients don’t like injectables, and some doctors don’t prescribe them, experts say.

The cholesterol-lowering drug is part of a suite of medicines that also includes MariTide and that Amgen Chief Medical ...

One of the terms you are likely to hear during your fertility treatment is Lupride injections. Starting fertility treatments ...

Phase 3 trial data found that people who took the investigational drug enlicitide with their routine cholesterol-lowering ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...

The new pill, enlicitide, blocks a liver protein, PCSK9, that slows the body’s ability to clear cholesterol. With most PCSK9 blocked, LDL levels plummet and rates of heart attacks and strokes in high ...